Cinctive Capital Management’s Quest Diagnostics DGX Stock Holding History

Cinctive Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,908	Closed	-$554K	–	421
2025 Q3	$554K	Buy	+2,908	New	+$516K	0.03%	341
2025 Q2	–	Sell	-4,488	Closed	-$759K	–	402
2025 Q1	$759K	Sell	4,488 -82,768	-95%	-$13.6M	0.06%	233
2024 Q4	$13.2M	Buy	87,256 +59,676	+216%	+$9.28M	0.67%	31
2024 Q3	$4.28M	Buy	+27,580	New	+$4.12M	0.23%	144
2023 Q1	–	Sell	-19,913	Closed	-$3.12M	–	439
2022 Q4	$3.12M	Buy	+19,913	New	+$2.86M	0.15%	208
2022 Q3	–	Sell	-31,582	Closed	-$4.2M	–	495
2022 Q2	$4.2M	Buy	+31,582	New	+$4.3M	0.18%	191
2020 Q3	–	Sell	-34,139	Closed	-$3.89M	–	306
2020 Q2	$3.89M	Buy	+34,139	New	+$3.62M	0.45%	83

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cinctive Capital Management's DGX Position: Q4 2025 in Review

Cinctive Capital Management sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 2,908 shares — an estimated $554K sold.

Cinctive Capital Management first reported a position in DGX in Q2 2020 and held it in 7 quarters. The position peaked at $13.2M in Q4 2024. 1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

Cinctive Capital Management reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
Cinctive Capital Management sold 2,908 Quest Diagnostics shares in Q4 2025, an estimated $554K.
Cinctive Capital Management first reported a position in Quest Diagnostics in Q2 2020 and held it in 7 quarters.
Cinctive Capital Management's Quest Diagnostics position peaked at $13.2M in Q4 2024.
1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Cinctive Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.